No description
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
Background: Among people living with HIV (PLWH), the prevalence of non-HIV related co-morbidities is increasing. Aim of the present study is to describe co-morbidity and multi-morbidity, their clustering mode and the potential disease-disease interactions in a cohort of Italian HIV patients. Methods: Cross-sectional analysis conducted by the...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
: This study reports on hospital admission and outcomes of 69 HIV-infected subjects who were diagnosed with SARS-CoV-2 infection between February and May 2020, in a network of Italian centers. Patients' characteristics and median days between symptoms and diagnosis were similar by hospital admission, whereas admitted patients were had lower...
Uploaded on: April 14, 2023 -
2022 (v1)Publication
The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross-sectional studies conducted over three different periods: 2005, 2011 and 2015.
Uploaded on: February 14, 2024 -
2022 (v1)Publication
The aim of the present study was to evaluate CD4/CD8 dynamics in patients on dolutegravir (DTG)-based two-drug regimens (2DRs) and compare them with DTG-containing triple-drug regimens (3DRs). A prospective observational study was performed in the context of the SCOLTA cohort. Experienced PWH with HIV-RNA < 50 copies/mL were included if they...
Uploaded on: February 11, 2024 -
2022 (v1)Publication
The purpose of this study is to evaluate the frequency of central nervous system adverse events (CNS-AE) on dolutegravir (DTG) and non-DTG containing ART, and their reversibility, in the observational prospective SCOLTA cohort. Factors associated with CNS-AE were estimated using a Cox proportional-hazards model. 4939 people living with HIV...
Uploaded on: February 11, 2024 -
2023 (v1)Publication
No description
Uploaded on: February 7, 2024